Eli Lilly Executive Compensation
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Eli Lilly discloses FY2025 compensation for 5 named executive officers, totaling $6.2M. David Ricks, the Chairman & CEO, accounts for 72% of that combined total.
David Ricks's total compensation rose 155% year-over-year, from $1.7M in FY2024 to $4.5M in FY2025.
Cash compensation (salary plus bonus) made up 99% of Eli Lilly's FY2025 tracked executive pay, with stock awards accounting for 0%.
Among 78 other Healthcare companies in this dataset, Eli Lilly's combined tracked executive pay of $6.2M ranks in the 29th percentile (industry median: $13.6M). Its highest-paid executive, David Ricks, ranks in the 42th percentile for top-executive pay in the sector (industry median: $6.3M).
Compensation figures on this page for Eli Lilly come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.